video

Annual MS Awareness Video – We want your Videos!

It’s time for MS & Me’s annual MS Awareness video.  We have once again partnered with MyCounterpane to bring you this video composed of...

Could Probiotics Help to Fight Multiple Sclerosis?

Breaking research from the Mayo Clinic uncovers a gut microbe that has the potential to treat autoimmune diseases, including multiple sclerosis. The intriguing findings...

Debra’s Promise: Comedian, Entertainer, Auto Salesman, Motivational Speaker, and Community Activist Teddy Trainor Strives...

Growing up the son of a single mother, Teddy Trainor watched his mom struggle to make ends meet.  Sometimes working three jobs, she somehow...

Amy Schumer Comforts Her Father Who is Living With MS 

Amy Schumer Comforts Her Father Who is Living With MS HER AMY IS TRUEComedian Amy Schumer is pulling out all the stops to help her...

Rare Event for PPMS Patients Hosted by Ocrevus Manufacturer

PPMS (Primary Progressive Multiple Sclerosis) patients rarely find local patient education events geared toward them.  Since the FDA (USA) approved the first treatment effective...

Biogen’s 8% Increase to Some MS Medications Could Provide a Boost in 2018

Market Watch reports Biogen Inc.'s BIIB, +4.90% recent price increases on multiple sclerosis drugs "could provide lift into '18," according to RBC Capital Markets...
video

Cladridbine for the Treatment of Multiple Sclerosis

Dr. Daniel Kantor speaks with Dr. Kottil Rammohan, Professor of Neurology at University of Miami and Director of the MS Center about Cladribine for...

Stigma can cause depression in multiple sclerosis patients

People living with MS who reported higher levels of stigma.Washington: According to a study, the stigma of Multiple Sclerosis can increase the risk of...

Phase 2 Trial of Ibudilast Shows Slowing of Brain Shrinkage in Progressive MS

Patients living with primary progressive multiple sclerosis have eagerly been awaiting the results from phase 2 of the ibudilast study. It is the hope...

Celgene announces data on its phase III relapsing MS Ozanimod experimental treatment

Study met the primary endpoint of annualized relapse rate (ARR) and key secondary MRI endpoints of T2 and GdE lesions, compared to interferon (IFN)...

Social Media

800FollowersFollow